Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline
Christoph Correll,Celso Arango,Andrea Fagiolini,Giulia Giordano,Stefan Leucht,Gonzalo Salazar de Pablo
DOI: https://doi.org/10.2147/ndt.s459450
IF: 2.989
2024-06-20
Neuropsychiatric Disease and Treatment
Abstract:Christoph U Correll, 1– 4 Celso Arango, 5 Andrea Fagiolini, 6 Giulia Maria Giordano, 7 Stefan Leucht, 4, 8 Gonzalo Salazar de Pablo 5, 9, 10 1 Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; 2 Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/ Northwell, Hempstead, NY, USA; 3 Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; 4 German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany; 5 Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain; 6 Department of Molecular Medicine, School of Medicine, University of Siena, Siena, Italy; 7 Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy; 8 Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany; 9 Child and Adolescent Mental Health Services (CAMHS) South London and Maudsley NHS Foundation Trust London, London, UK; 10 Department of Child and Adolescent Psychiatry Institute of Psychiatry, Psychology & Neuroscience King's College London, London, UK Correspondence: Christoph U Correll, The Zucker Hillside Hospital, Department of Psychiatry, 75-59 263rd Street Glen Oaks, New York, NY, 11004, USA, Email Background: Schizophrenia is most times a chronic and often debilitating illness associated with poor mental health outcomes. Early and effective treatment of schizophrenia in the most appropriate setting can make a significant difference in the long-term recovery. The aim of this narrative review was to provide suggestions and recommendations for effectively managing patients with schizophrenia during acute exacerbations and to enhance awareness and skills related to personalized medicine. Methods: A panel of academics and clinicians with experience in the field of psychosis met virtually on July 13 th 2023 to narratively review and discuss the research evidence and their clinical experience about the most appropriate acute treatments for patients with schizophrenia. This manuscript represents a synthesis of the panel analysis and discussion. Results: First contact is very important for service users, as is finding the most adequate treatment setting. If patients present to the emergency department, which may be a traumatic setting for service users, a dedicated environment with adequate space and specialized mental health support, including personnel trained in de-escalation techniques, is recommended. A well-connected continuum of care is strongly recommended, possibly with seamless links between inpatient units, day hospital services, outpatient facilities and rehabilitation services. Ideally, this should be structured as part of a coordinated step-down service line. Treatment challenges include suboptimal response, side effects, and nonadherence, which is reduced by the use of long-acting injectable antipsychotics. Conclusion: Individual circumstances, including age, gender, and presence of hostility/aggression or self-harm, cognitive impairment and negative symptoms, comorbidities (depression, substance use disorders) or associated symptoms (anxiety, insomnia), should be considered when selecting the most appropriate treatment for the acute phase of schizophrenia. Efficacy and feasibility, as well as acceptability and tolerability of treatments, require joint consideration from the early stages of schizophrenia, thereby enhancing the possibility of improved short- and long-term outcomes. Keywords: schizophrenia, first-episode psychosis, acute setting, clinical care Schizophrenia is most times a chronic and often debilitating illness that is associated with positive, negative and cognitive symptoms, impaired reward processing and illness insight, as well as poor functional and physical health outcomes. 1–3 Although genetic and environmental factors have been implicated, including maternal infection due to seasonal birth findings, 4 the pathophysiology of schizophrenia remains to be elucidated, and valid biomarkers are lacking. 5 The median age at the onset of schizophrenia and schizophrenia-spectrum disorders (first-episode psychosis) is 20.5 years. 6 All-cause mortality is increased in people with schizophrenia compared to the general population with the greatest risk in first-episode (RR = 7.4) and incident (ie, earlier-phase) schizophre -Abstract Truncated-
psychiatry,clinical neurology